Biotech: Bubble Or Opportunity? |
| October 16, 2015 | October 2015 Bond Updates |
|
Biotech stocks have hit a rough patch in recent weeks. The S&P 500 Biotech Index has fallen around 20% since its high point July, as investors have grown worried about the impact China could have on global growth, and the potential for regulatory policy changes that could affect drug pricing. |
| View more at: http://www.forbes.com/sites/fidelity/2015/10/15/biotech-bubble-or-opportunity/ |
| Related News |
|